Kenichiro Hata

Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study

K. Ohmura, Hiromu Ito, M. Hashimoto, 2022, Rheumatology International.

Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients

S. Takai, T. Hanafusa, K. Hata, 2014, Journal of Human Hypertension.

Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis

T. Kotani, Y. Wada, T. Takeuchi, 2023, International Journal of Molecular Sciences.

Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.

M. Hashimoto, W. Yamamoto, K. Ebina, 2023, Rheumatology.